- Home
- RXRX vs LMAT Comparison
RXRX vs LMAT Comparison
Compare RXRX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- LMAT
- Stock Information
- Founded
- RXRX 2013
- LMAT 1983
- Country
- RXRX United States
- LMAT United States
- Employees
- RXRX N/A
- LMAT N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- LMAT Medical/Dental Instruments
- Sector
- RXRX Health Care
- LMAT Health Care
- Exchange
- RXRX Nasdaq
- LMAT Nasdaq
- Market Cap
- RXRX 2.0B
- LMAT 1.9B
- IPO Year
- RXRX 2021
- LMAT 2006
- Fundamental
- Price
- RXRX $5.28
- LMAT $83.69
- Analyst Decision
- RXRX Buy
- LMAT Buy
- Analyst Count
- RXRX 5
- LMAT 6
- Target Price
- RXRX $7.00
- LMAT $100.80
- AVG Volume (30 Days)
- RXRX 29.9M
- LMAT 152.3K
- Earning Date
- RXRX 08-07-2025
- LMAT 08-05-2025
- Dividend Yield
- RXRX N/A
- LMAT 0.93%
- EPS Growth
- RXRX N/A
- LMAT 30.45
- EPS
- RXRX N/A
- LMAT 1.97
- Revenue
- RXRX $59,790,000.00
- LMAT $226,256,000.00
- Revenue This Year
- RXRX $23.51
- LMAT $13.88
- Revenue Next Year
- RXRX $53.87
- LMAT $8.81
- P/E Ratio
- RXRX N/A
- LMAT $42.49
- Revenue Growth
- RXRX 29.32
- LMAT 13.19
- 52 Week Low
- RXRX $3.79
- LMAT $71.42
- 52 Week High
- RXRX $12.36
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- RXRX 52.46
- LMAT 50.89
- Support Level
- RXRX $4.80
- LMAT $82.76
- Resistance Level
- RXRX $5.88
- LMAT $86.94
- Average True Range (ATR)
- RXRX 0.38
- LMAT 2.10
- MACD
- RXRX 0.03
- LMAT 0.18
- Stochastic Oscillator
- RXRX 48.32
- LMAT 47.92
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.